Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir PK in Pediatric Oncology
NCT00042328Phase 2Completed
- Sponsor
- Baylor College of Medicine
- Start
- Aug 2001
- Primary completion
- May 2005
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of valaciclovir in herpes simplex virus infection, herpes zoster (HZ) and varicella zoster virus infection, sponsored by Baylor College of Medicine. Primary endpoint: Pharmacokinetic parameters at 8 hours. Started Aug 2001; status: completed.
02
Drugs
valaciclovir
03
Conditions
herpes simplex virus infectionherpes zoster (HZ)varicella zoster virus infection
Beyond the preview
Go deeper on NCT00042328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042328.